Model Medicines
Daniel Haders is the founder and CEO of Model Medicines, a company that is working to make clinical trials more efficient and effective. Prior to Model Medicines, Daniel was the CEO of AppliedVR, a company that uses virtual reality to help people with pain management. Daniel has also served as the Senior Strategic Advisor at QuiO, a company that makes it easier for patients to access their medication. Daniel has a background in venture capital, having worked at Columbia Technology Ventures and Sway Ventures. Daniel has also worked as an advisor for MedCrypt, a company that provides data security for medical devices.
Daniel Haders II has a BS from Columbia University in the City of New York in Biomedical Engineering & Materials Science and Engineering. Daniel also has an MBA from Harvard Business School in Leadership and Strategy in Pharmaceuticals and Biotech. Daniel has a Ph.D. from Rutgers University in Biomedical Engineering & Materials Science and Engineering. Daniel is also a Recognized Visiting Graduate Student from the University of Oxford in Materials Science and Engineering.
Bastiaan Bergman - Director of Engineering, Sean M. Russell - Founder & VP of Regulatory, and Divya Ramamoorthy - Fellow report to Daniel Haders II.
Model Medicines
Model Medicines is transforming drug discovery by leveraging the historical compendium of drug development data and unbiased AI to create Phase II/III ready drug candidates in days rather than decades.